Role of Tumoral Biomarker B3 Adrenergic Receptor in Paediatric Solid Tumours

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Tumor
Interventions
OTHER

Analysis of peripheral blood (control group)

Peripheral blood sample will be acquired in excess to the last scheduled control sample according to clinical practice.

OTHER

Analysis of biological sample (Substudy-solid neoplasms)

peripheral blood sample, bone marrow aspirate and fresh or paraffin biopsia tissutale will be collected for the substudy

OTHER

Analysis of biological sample (substudy-leukaemia patients)

sample of peripheral blood and bone marrow blood for the substudy, derived from paediatric or young adult leukaemia patients

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Ospedale San Donato di Arezzo, Arezzo

RECRUITING

Meyer Children's Hospital IRCCS, Florence

ACTIVE_NOT_RECRUITING

Azienda Ospedaliera Pisana, Pisa

All Listed Sponsors
lead

Meyer Children's Hospital IRCCS

OTHER